PDF(Pubmed)
Abstract：
The 21st Association for Cancer Immunotherapy (CIMT) Annual Meeting took place from May 15th to May 17th in Mainz, Germany, and was attended by a total of 855 academic and clinical professionals hailing from 33 different countries. The conference served as a platform for these experts to convene and discuss the latest breakthroughs in cancer immunology and immunotherapy research. Dedicated sessions covering advancements in artificial intelligence tools for cancer immunotherapy research, as well as the landscape of cancer care and cancer immunotherapy trials on the African continent, prompted lively and informative discussions among the attendees. This report aims to provide an overview of the most noteworthy highlights and key takeaways from CIMT2024.
摘要：
第21届癌症免疫治疗协会（CIMT）年会于5月15日至5月17日在美因茨举行，德国,来自33个不同国家的855名学术和临床专业人员参加了会议。会议为这些专家召集和讨论癌症免疫学和免疫疗法研究的最新突破提供了平台。专门的会议涵盖了用于癌症免疫治疗研究的人工智能工具的进步，以及非洲大陆癌症治疗和癌症免疫治疗试验的前景，在与会者中引发了生动而翔实的讨论。本报告旨在概述MT2024年CI最值得注意的亮点和主要收获。
